This study examined receipt of a well-woman visit (WWV) and cervical cancer screening (CCS) at the intersection of sexual orientation and race/ethnicity among Illinois women aged 21–65.
Methods:
This study used 2016, 2018, and 2020 Illinois Behavioral Risk Factor Surveillance System (BRFSS) data for women aged 21–65 to examine rates of CCS (n = 2848) and 2016–2018, 2020, and 2021 Illinois BRFSS data to examine WWV receipt (n = 5863) by sexual orientation (heterosexual vs. lesbian, gay, and bisexual [LGB]). Self-reported race/ethnicity was tested as an effect modifier to assess intersectionality. Using binomial regression, adjusted prevalence differences (aPD) and 95% confidence intervals (CIs) were estimated. Covariates included age, education, marital status, employment, and health insurance coverage.
Results:
Overall, 4.6% of Illinois women aged 21–65 self-identified as LGB. Heterosexual and LGB women had a similar prevalence of receipt of both a WWV (77.1% and 71.7%, respectively; aPD = 3.22, 95% CI: −3.62 to 10.06) and CCS (85.3% and 83.4%, respectively; aPD = 2.13, 95% CI: −4.77 to 9.04). Among non-Hispanic (NH) Black women, heterosexual compared with LGB women had a higher prevalence of receiving both types of care; however, adjusted associations included the null. Hispanic women had similar prevalence estimates by sexual orientation for both outcomes, and NH White heterosexual compared with LGB women had a higher prevalence of CCS, but not WWV.
Conclusion:
In Illinois overall, heterosexual and LGB women received preventive care at similar rates. However, when stratified by race/ethnicity, WWV and CCS receipt rates may be higher for heterosexual compared with LGB women, indicating potential missed opportunities for preventive care.
DickinsonJA, StankiewiczA, PopadiukC, et al.Reduced cervical cancer incidence and mortality in Canada: National data from 1932 to 2006. BMC Public Health, 2012; 12(1):992; doi: 10.1186/1471-2458-12-992
6.
ScarinciIC, GarciaFAR, KobetzE, et al.Cervical cancer prevention: New tools and old barriers. Cancer, 2010; 116(11):2531–2542; doi: 10.1002/cncr.25065
7.
CollinsY, HolcombK, Chapman-DavisE, et al.Gynecologic cancer disparities: A report from the Health Disparities Taskforce of the Society of Gynecologic Oncology. Gynecol Oncol, 2014; 133(2):353–361; doi: 10.1016/j.ygyno.2013.12.039
8.
BustamanteG, ReiterPL, McReeAL. Cervical cancer screening among sexual minority women: Findings from a national survey. Cancer Causes Control, 2021; 32(8):911–917; doi: 10.1007/s10552-021-01442-0
9.
BenardVB, LawsonHW, EhemanCR, et al.Adherence to guidelines for follow-up of low-grade cytologic abnormalities among medically underserved women. Obstet Gynecol, 2005; 105(6):1323–1328; doi: 10.1097/01.AOG.0000159549.56601.75
10.
Chido-AmajuoyiOG, SheteS, TalluriR, et al.Prevalence of abnormal cervical cancer screening outcomes among women in the United States: Results from the National Health Interview Survey, 2018. Am J Obstet Gynecol, 2020; 223(6):938–941; doi: 10.1016/j.ajog.2020.08.050
11.
ChatterjeeS, GuptaD, CaputoTA, et al.Disparities in gynecological malignancies. Front Oncol, 2016; 6:36; doi: 10.3389/fonc.2016.00036
12.
MusselwhiteLW, OliveiraCM, KwarambaT, et al.Racial/ethnic disparities in cervical cancer screening and outcomes. Acta Cytol, 2016; 60(6):518–526; doi: 10.1159/000452240
13.
Centers for Disease Control and Prevention. Rate of New Cancers by Race and Ethnicity, Cervix. Atlanta, GA. Available from: https://gis.cdc.gov/grasp/USCS/DataViz.html [Last accessed: April17, 2024].
14.
FordS, TarrafW, WilliamsKP, et al.Differences in cervical cancer screening and follow-up for Black and White women in the United States. Gynecol Oncol, 2021; 160(2):369–374; doi: 10.1016/j.ygyno.2020.11.027
MillerKD, OrtizAP, PinheiroPS, et al.Cancer statistics for the US Hispanic/Latino population, 2021. CA Cancer J Clin, 2021; 71(6):466–487; doi: 10.3322/caac.21695
JacksonCL, AgénorM, JohnsonDA, et al.Sexual orientation identity disparities in health behaviors, outcomes, and services use among men and women in the United States: A cross-sectional study. BMC Public Health, 2016; 16(1):807; doi: 10.1186/s12889-016-3467-1
20.
TrinhMH, AgénorM, AustinSB, et al.Health and healthcare disparities among U.S. women and men at the intersection of sexual orientation and race/ethnicity: A nationally representative cross-sectional study. BMC Public Health, 2017; 17(1):964; doi: 10.1186/s12889-017-4937-9
21.
TabaacAR, SolazzoAL, GordonAR, et al.Sexual orientation-related disparities in healthcare access in three cohorts of U.S. adults. Prev Med, 2020; 132:105999; doi: 10.1016/j.ypmed.2020.105999
22.
McDonaldKM, DelgadoA, RoecknerJT. Papanicolaou test rates among sexual minority women: A systematic review and meta-analysis. LGBT Health, 2022; 9(1):1–7; doi: 10.1089/lgbt.2020.0423
23.
AgénorM, KriegerN, AustinSB, et al.At the intersection of sexual orientation, race/ethnicity, and cervical cancer screening: Assessing Pap test use disparities by sex of sexual partners among Black, Latina, and White U.S. women. Soc Sci Med, 2014; 116:110–118; doi: 10.1016/j.socscimed.2014.06.039
24.
LinE, SlebodaP, RimelBJ, et al.Sexual orientation and gender identity inequities in cervical cancer screening by race and ethnicity. Cancer Causes Control, 2024; 35(1):133–151; doi: 10.1007/s10552-023-01771-2
25.
DowningJM, RosenthalE. Prevalence of social determinants of health among sexual minority women and men in 2017. Am J Prev Med, 2020; 59(1):118–122; doi: 10.1016/j.amepre.2020.01.007
MatthewsAK, BreenE, KittiteerasackP. Social determinants of LGBT cancer health inequities. Semin Oncol Nurs, 2018; 34(1):12–20; doi: 10.1016/j.soncn.2017.11.001
29.
HsiehN, RutherM. Despite increased insurance coverage, nonwhite sexual minorities still experience disparities in access to care. Health Aff (Millwood), 2017; 36(10):1786–1794; doi: 10.1377/hlthaff.2017.0455
30.
MartinP, LiawW, BazemoreA, et al.Adults with housing insecurity have worse access to primary and preventive care. J Am Board Fam Med, 2019; 32(4):521–530; doi: 10.3122/jabfm.2019.04.180374
31.
NolanJ, RenderosTB, HynsonJ, et al.Barriers to cervical cancer screening and follow‐up care among Black women in Massachusetts. J Obstet Gynecol Neonatal Nurs, 2014; 43(5):580–588; doi: 10.1111/1552-6909.12488
32.
WalkerMJ, ChiarelliAM, KnightJA, et al.Perceived risk and adherence to breast cancer screening guidelines among women with a familial history of breast cancer: A review of the literature. Breast, 2013; 22(4):395–404; doi: 10.1016/j.breast.2012.12.005
33.
AckersonK, DoaneL. Psychometric testing of the Pap smear belief questionnaire: Measuring women’s attitudes and beliefs toward cervical cancer screening. J Nurs Meas, 2017; 25(1):77–89; doi: 10.1891/1061-3749.25.1.77
TracyJK, LydeckerAD, IrelandL. Barriers to cervical cancer screening among lesbians. J Womens Health (Larchmt), 2010; 19(2):229–237; doi: 10.1089/jwh.2009.1393
36.
WaughE, MyhreD, BeauvaisC, et al.Preventive screening in women who have sex with women. Can Fam Physician, 2021; 67(11):830–836; doi: 10.46747/cfp.6711830
37.
CurmiC, PetersK, SalamonsonY. Lesbians’ attitudes and practices of cervical cancer screening: A qualitative study. BMC Womens Health, 2014; 14:153; doi: 10.1186/s12905-014-0153-2
38.
AgénorM, BaileyZ, KriegerN, et al.Exploring the cervical cancer screening experiences of Black lesbian, bisexual, and queer women: The role of patient-provider communication. Women Health, 2015; 55(6):717–736; doi: 10.1080/03630242.2015.1039182
39.
ChristyK, KandasamyS, MajidU, et al.Understanding Black women’s perspectives and experiences of cervical cancer screening: A systematic review and qualitative meta-synthesis. J Health Care Poor Underserved, 2021; 32(4):1675–1697; doi: 10.1353/hpu.2021.0159
40.
BowlegL. When Black + lesbian + woman ≠ Black lesbian woman: The methodological challenges of qualitative and quantitative intersectionality research. Sex Roles, 2008; 59(5–6):312–325; doi: 10.1007/s11199-008-9400-z
41.
TemkinSM, RimelBJ, BrueglAS, et al.A contemporary framework of health equity applied to gynecologic cancer care: A Society of Gynecologic Oncology evidenced-based review. Gynecol Oncol, 2018; 149(1):70–77; doi: 10.1016/j.ygyno.2017.11.013
42.
FaluN. Ain’t I too a mulher? Implications of Black lesbians’ well‐being, self‐care, and gynecology in Brazil. J Latin Amer Carib Anth, 2020; 25(1):48–66; doi: 10.1111/jlca.12464
BowlegL. Evolving intersectionality within public health: From analysis to action. Am J Public Health, 2021; 111(1):88–90; doi: 10.2105/AJPH.2020.306031
45.
BowlegL. The problem with the phrase women and minorities: Intersectionality—an important theoretical framework for public health. Am J Public Health, 2012; 102(7):1267–1273; doi: 10.2105/AJPH.2012.300750
46.
Centers for Disease Control and Prevention. Behavioral Risk Factor Surveillance System. Atlanta, GA. 2024. Available from: https://www.cdc.gov/brfss/index.html [Last accessed: April10, 2024].
47.
Illinois Department of Public Health. Illinois Behavioral Risk Factor Surveillance System. Chicago, IL. Available from: http://www.idph.state.il.us/brfss/default.asp [Last accessed: April10, 2024].
48.
CurrySJ, KristAH, OwensDK, et al.; US Preventive Services Task Force. Screening for cervical cancer: US Preventive Services Task Force recommendation statement. JAMA, 2018; 320(7):674–686; doi: 10.1001/jama.2018.10897
49.
Snapshot: LGBTQ Equality by State. Movement Advancement Project. Boulder, CO. Available from: https://www.lgbtmap.org/equality-maps [Last accessed: April24, 2024].
50.
MartosAJ, WilsonPA, MeyerIH. Lesbian, gay, bisexual, and transgender (LGBT) health services in the United States: Origins, evolution, and contemporary landscape. PLoS ONE, 2017; 12(7):e0180544; doi: 10.1371/journal.pone.0180544
